How to Develop a National Formulary Based on the WHO Model Formulary - A Practical Guide
(2004; 45 pages) View the PDF document
Table of Contents
View the documentAbbreviations
Open this folder and view contents1 INTRODUCTION
Open this folder and view contents2 OVERVIEW OF THE NATIONAL FORMULARY PROCESS
Open this folder and view contents3 DEVELOPING THE PRELIMINARY INFORMATION SECTION
Open this folder and view contents4 DEVELOPMENT OF THERAPEUTIC INFORMATION AND MONOGRAPHS USING THE WHO MODEL FORMULARY
Close this folder5 ADDITIONAL SOURCES OF INFORMATION
View the documentThe evidence-based approach in formulary development
View the documentInformation retrieval
Close this folderTypes of source
View the documentPrimary information sources
View the documentSecondary information sources
View the documentTertiary information sources
View the documentManufacturer’s literature
Open this folder and view contentsSearching for the best evidence
Open this folder and view contentsAccessibility
View the documentCritical appraisal
Open this folder and view contents6 DEVELOPING SPECIFIC INFORMATION SECTIONS
Open this folder and view contents7 PRODUCTION, DISTRIBUTION AND IMPLEMENTATION
Open this folder and view contents8 EVALUATION
Open this folder and view contents9 REVIEW AND UPDATE
View the documentREFERENCES
 

Tertiary information sources

Tertiary information sources generally present a summary of well-established and documented drug and therapeutic information and include textbooks, formularies, drug compendia and electronic drug databases. Several of these basic references are available electronically, but they are most commonly available as printed books. They may contain outdated information because of the delays in producing and publishing such texts.

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: March 20, 2014